A randomised controlled trial of calcineurin inhibitor (CNI) replacement with mycophenolate mofetil and steroids in liver transplant patients with renal dysfunction.

被引:0
|
作者
Day, CP
O'Grady, J
Mayer, D
Simpson, K
Millson, CE
Solomons, N
Duncan, J
Bechter, M
Patch, D
机构
[1] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Kings Coll Hosp London, London, England
[3] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
[4] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland
[5] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England
[6] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[7] Royal Free Hosp, London NW3 2QG, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:547A / 547A
页数:1
相关论文
共 50 条
  • [31] Mycophenolate mofetil: An alternative maintenance immunosuppressant in liver transplantation, which improves renal dysfunction.
    Papatheodoridis, GV
    O'Beirne, J
    Mistry, P
    Davidson, B
    Rolles, K
    Burroughs, AK
    [J]. HEPATOLOGY, 1998, 28 (04) : 267A - 267A
  • [32] Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil:: A meta-analysis of randomized, controlled trials
    Pascual, J
    Quereda, C
    Zamora, J
    Hernández, D
    [J]. TRANSPLANTATION, 2004, 78 (10) : 1548 - 1556
  • [33] Rapid reduction of mycophenolate mofetil and calcineurin inhibitor dose for treating cytomegalovirus infection in renal transplant patients.
    Lin, Kuo Jen
    Wang, Hsu-Han
    Lin, Chih-Te
    Pan, Pai-Yen
    Chen, Sy-Yuan
    [J]. TRANSPLANTATION, 2024, 108 (09) : 592 - 592
  • [34] Effects of mycophenolate mofetil, IL2r blockade and delayed introduction of calcineurin inhibitor (CNI) on gfr in liver transplant: 12 month data from a multi-centre randomised controlled study
    Neuberger, James M.
    Mayer, A. David
    Neuhaus, Peter
    Pirenne, Jacques
    Samuel, Didier
    Rimola, Antoni
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
  • [35] Combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients is nephro- and hepatoprotective
    Cicinnati, V. R.
    Yu, Z.
    Klein, C. G.
    Sotiropoulos, G.
    Sahner, F.
    Gerken, G.
    Beckebaum, S.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S87 - S87
  • [36] Renal Allograft Outcome in Combined Liver-Kidney Transplant (CLKT) on Calcineurin Inhibitor (CNI) vs. CNI and Mycophenolate (M) Maintenance Immunosuppression.
    Campara, Maya
    Jeon, Hoonbae
    Tzvetanov, Ivo
    Oberholzer, Jose
    Benedetti, Enrico
    Tang, Ignatius
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 533 - 534
  • [37] Mycophenolate mofetil rescue of calcineurin inhibitor related nephrotoxicity in children after liver transplant.
    Samaroo, B
    Dhawan, A
    Baker, AJ
    Rela, M
    Muiesan, P
    Verma, A
    Hadzic, N
    Heaton, ND
    Mieli-Vergani, G
    [J]. HEPATOLOGY, 2000, 32 (04) : 343A - 343A
  • [38] Sirolimus (rapamycin) as rescue therapy in liver transplant recipients with chronic rejection and calcineurin inhibitor induced renal dysfunction.
    Sultan, S
    Tuttle-Newhall, JE
    Rockey, DC
    Muir, AJ
    Bornstein, JD
    Collins, B
    Kuo, PC
    Heneghan, MA
    [J]. HEPATOLOGY, 2002, 36 (04) : 662A - 662A
  • [39] Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation
    Pageaux, Georges-Philippe
    Rostaing, Lionel
    Calmus, Yvon
    Duvoux, Christophe
    Vanlemmens, Claire
    Hardgwissen, Jean
    Bernard, Pierre-Henri
    Barbotte, Eric
    Vercambre, Lucille
    Bismuth, Michael
    Puche, Pierre
    Navarro, Francis
    Larrey, Dominique
    [J]. LIVER TRANSPLANTATION, 2006, 12 (12) : 1755 - 1760
  • [40] Calcineurin Inhibitor Sparing With Mycophenolate Mofetil in Liver Transplantion: A Systematic Review of Randomized Controlled Trials
    Goralczyk, A. D.
    Bari, N.
    Abu-Ajaj, W.
    Lorf, T.
    Ramadori, G.
    Friede, T.
    Obed, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (10) : 2601 - 2607